Drug Discovery

Repurposing drugs could accelerate the development of a new cystic fibrosis drug.

Sitting down with… Matthew Todd, Chair of Drug Discovery at UCL and founder of the Open Source Pharma movement.

What challenges do manufacturers face in developing ADCs?

How is pharma using advances in technology to its benefit?

What needs to change to improve our odds in the fight against AMR?

What type of dosage form would a patient prefer to take? Additive manufacturing provides the ultimate flexibility.

Why virtual and augmented reality technologies are the future of workforce training.

Jeroen den Hertog from the Hubrecht Institute is exploring the bioactive properties of fungal strains.

A novel small molecule aims to tackle both Alzheimer’s disease and Dravet syndrome.

Dale Thomas, Co-founder of Mytide, explains how AI can be used for the discovery and development of peptide therapeutics.